Development of a live vaccine against feline leukemia. Experiment outside containment (clinical trial) for the study of the safety of a subcutaneous administration of a recombinant canarypoxvirus expressing FELV genes.

EU record number

B/BE/97/VW9

cats

vaccination against feline leukemia virus (FELV)

env and gag genes of the type A virus of feline leukemia (FELV)

Canarypoxvirus (ALVAC clone)

subcutaneous

Merksem, Heverlee, Mechelen, Deurne, Izegem, Haine St Pierre, Ternat, Overijse, Liège

400

6 months

Deliberate release only

6 April 1997: The Biosafety Advisory Council a.i. issues a positive advice (with conditions) for this trial.